Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Reports advance knowledge in cancer vaccines research
July 25th, 2005
Reports from The Netherlands, United States and Germany highlight recent research on cancer vaccines. Study 1: Researchers have identified a recombinant protein that causes restricted apoptosis in human leukemic T cells. According to a study from the Netherlands and Germany, "Current treatment of human T-cell leukemia and lymphoma is predominantly limited to conventional cytotoxic therapy and is associated with limited therapeutic response and significant morbidity. Therefore, more potent and leukemia-specific therapies with favorable toxicity profiles are urgently needed. Here, we report on the construction of a novel therapeutic fusion protein,...
Source: Health & Medicine Week (2005-07-25)
|
